As part of ongoing work with entrepreneurs and innovative businesses worldwide, MTIF Scientists pushed forward product development of NEEM by Sunita Passi, utilising MTIF’s microbiology suite of services, part of our best in class expertise and research services.
MTIF scientist Amy Kerry worked with Tri-Dosha founder Sunita Passi to look into the cytotoxicity of the active ingredient in Tri-Dosha’s range of products, the plant derived Neem. The highly successful study demonstrated that 1% and 0.5% Neem showed no significant cytotoxicity in human primary skin cells.
Sunita Passi on the project at MTIF:
Collaborating with MTIF has been an incredible opportunity for us to advance our understanding of Neem and its potential in skincare. Their expertise helped us validate our formulations, ensuring they’re both safe and effective. This research is a big step forward in our product development.
Click to find out about Tri-Dosha and NEEM by Sunita Passi.
Tri-Dosha utilised an RTO grant from Innovate UK in order to pushforward development of their Neem suite of healthcare, skincare and haircare products. Novel ideas and innovative companies can find out more about RTO grants here.
MTIF has a long history of supporting novel product development, whether its cleanrooms, analytical services or cell therapies, our in house expertise, alongside cutting edge equipment can help you meet your project goals.
Utilising our research expertise and facilities has helped push forward products in the healthcare space and beyond.
We can help you to turn your research goals into reality. Talk to us today and see how our expertise can assist you.